Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based Johnson & Johnson (J&J) is in discussions with the Government of Japan, as well as the Bill and Melinda Gates Foundation, regarding allocations of its Covid-19 vaccine candidate.
In an interview with Reuters, J&J chief financial officer Joseph Wolk said that the company already agreed to an allocation deal with the US as part of its funding agreement with the US Biomedical Advanced Research and Development Authority (BARDA).
The Bill and Melinda Gates Foundation intends to provide any vaccine it acquired to developing countries, noted Wolk. According to a previous report by Reuters, J&J is also in discussions with the.